<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.beaconcancer.org/index.php?action=history&amp;feed=atom&amp;title=KRAS</id>
	<title>KRAS - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.beaconcancer.org/index.php?action=history&amp;feed=atom&amp;title=KRAS"/>
	<link rel="alternate" type="text/html" href="https://wiki.beaconcancer.org/index.php?title=KRAS&amp;action=history"/>
	<updated>2026-10-17T03:41:02Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.39.5</generator>
	<entry>
		<id>https://wiki.beaconcancer.org/index.php?title=KRAS&amp;diff=22011&amp;oldid=prev</id>
		<title>Victor at 14:24, 27 August 2024</title>
		<link rel="alternate" type="text/html" href="https://wiki.beaconcancer.org/index.php?title=KRAS&amp;diff=22011&amp;oldid=prev"/>
		<updated>2024-08-27T14:24:11Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 14:24, 27 August 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;KRAS is a gene that encodes a protein involved in cell signaling pathways that regulate cell growth, division, and survival. Mutations in the KRAS gene are among the most common genetic alterations in cancers, particularly in pancreatic, colorectal, and lung cancers. These mutations result in the continuous activation of the KRAS protein, leading to uncontrolled cell proliferation and &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumor &lt;/del&gt;development. Identifying KRAS mutations in &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumors &lt;/del&gt;is crucial for determining the most effective treatment strategies, as these mutations often indicate resistance to certain therapies, such as anti-EGFR monoclonal antibodies. By understanding the presence and role of KRAS mutations, clinicians can better tailor treatments to each patient&amp;#039;s specific cancer profile, potentially improving outcomes and offering more personalized cancer care.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;KRAS is a gene that encodes a protein involved in cell signaling pathways that regulate cell growth, division, and survival. Mutations in the KRAS gene are among the most common genetic alterations in cancers, particularly in pancreatic, colorectal, and lung cancers. These mutations result in the continuous activation of the KRAS protein, leading to uncontrolled cell proliferation and &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumour &lt;/ins&gt;development. Identifying KRAS mutations in &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumours &lt;/ins&gt;is crucial for determining the most effective treatment strategies, as these mutations often indicate resistance to certain therapies, such as anti-EGFR monoclonal antibodies. By understanding the presence and role of KRAS mutations, clinicians can better tailor treatments to each patient&amp;#039;s specific cancer profile, potentially improving outcomes and offering more personalized cancer care.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Victor</name></author>
	</entry>
	<entry>
		<id>https://wiki.beaconcancer.org/index.php?title=KRAS&amp;diff=18043&amp;oldid=prev</id>
		<title>Victor: Created page with &quot;KRAS is a gene that encodes a protein involved in cell signaling pathways that regulate cell growth, division, and survival. Mutations in the KRAS gene are among the most common genetic alterations in cancers, particularly in pancreatic, colorectal, and lung cancers. These mutations result in the continuous activation of the KRAS protein, leading to uncontrolled cell proliferation and tumor development. Identifying KRAS mutations in tumors is crucial for determining the...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wiki.beaconcancer.org/index.php?title=KRAS&amp;diff=18043&amp;oldid=prev"/>
		<updated>2024-05-21T18:02:24Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;KRAS is a gene that encodes a protein involved in cell signaling pathways that regulate cell growth, division, and survival. Mutations in the KRAS gene are among the most common genetic alterations in cancers, particularly in pancreatic, colorectal, and lung cancers. These mutations result in the continuous activation of the KRAS protein, leading to uncontrolled cell proliferation and tumor development. Identifying KRAS mutations in tumors is crucial for determining the...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;KRAS is a gene that encodes a protein involved in cell signaling pathways that regulate cell growth, division, and survival. Mutations in the KRAS gene are among the most common genetic alterations in cancers, particularly in pancreatic, colorectal, and lung cancers. These mutations result in the continuous activation of the KRAS protein, leading to uncontrolled cell proliferation and tumor development. Identifying KRAS mutations in tumors is crucial for determining the most effective treatment strategies, as these mutations often indicate resistance to certain therapies, such as anti-EGFR monoclonal antibodies. By understanding the presence and role of KRAS mutations, clinicians can better tailor treatments to each patient&amp;#039;s specific cancer profile, potentially improving outcomes and offering more personalized cancer care.&lt;/div&gt;</summary>
		<author><name>Victor</name></author>
	</entry>
</feed>